Abstracts

653 – TFV-DP Is Associated With Baseline Virologic Suppression in PWH on TAF: Results From ACTG A5359

Background Tenofovir (TFV)-diphosphate (TFV-DP) concentrations in dried blood spots (DBS) demonstrate strong associations with adherence, virologic suppression (VS) and future viremia in persons with HIV (PWH) but data are limited to the older TFV prodrug or PWH with VS on TFV alafenamide (TAF). We examined TFV-DP in DBS and its association with VS at baseline among…

797 – Vascular Endothelial Growth Factor Receptor 3 (VEGFR3/FLT4) Regulates the KSHV Replication Cycle

Background Kaposi sarcoma-associated herpesvirus (KSHV) is the etiologic agent of the AIDS-defining cancer Kaposi sarcoma (KS). Despite widespread use of antiretroviral therapy, KSHV seroprevalence remains at 40% in HIV+ individuals in the US. HIV infection promotes KS development via angiogenic and pro-inflammatory factors and KSHV infection drives angiogenesis as observed in highly vascularized KS lesions…

779 – A New Point-of-Care Ultrasound Protocol for Chronic Hepatitis B and HBV/HIV Coinfection in Zambia

Background Background: Point-of-care ultrasound (POCUS) has emerged globally as inexpensive tool used by various healthcare professionals. We evaluated the accuracy of a novel point-of-care liver ultrasound protocol for hepatitis (PUSH) in detecting significant fibrosis, cirrhosis, and suspicious liver lesions in Zambia.  Methods Method: we performed a real-world validation of the PUSH at University Teaching hospital in Lusaka, Zambia, from March…

511 – Development and Delivery of Next-Generation Epigenome Editors for Long-Term HIV Silencing

Background Although antiretroviral therapy (ART) has extended the lifespan of people living with HIV (PLWH), it cannot eliminate genome-integrated HIV reservoirs. Approximately 81% of the reservoir remains transcriptionally active, driving immune activation and rapid viral rebound. Silencing these transcriptionally active reservoirs is crucial. Recent studies highlight that DNA and histone methylation can effectively silence cellular…

466 – Mapping the Spatial Landscape of Lymph Nodes With Undetectable Versus Active HIV Replication

Background Despite its effectiveness in suppressing active HIV replication, antiretroviral therapy (ART) does not eliminate the long-lived pool of HIV reservoir cells. Lymphoid tissues are a major reservoir even in the context of ART, but most studies on latent reservoirs focus on peripheral blood. The complex interplay between immune cells and the mechanisms that maintain…

559 – Paucity of HIV Envelope Expressing Cells Upon Latency Reversal in ART-Suppressed PWH

Background Antiretroviral therapy (ART) effectively suppresses HIV-1 replication but fails to eradicate the virus, as HIV-1 persists in long-lived reservoirs. Therefore, novel strategies are needed to detect and eliminate them. The HIV-1 envelope glycoprotein (Env) is the only viral antigen expressed on the surface of infected cells, making it a prime target for immunotherapies. While current…

538 – Phase I Clinical Trial AMC097 Evaluating Engraftment and HIV Resistance of Gene-Modified Blood Cells

Background For HIV patients, there is currently no effective cure.  Approaches involving stem cell and gene therapies aimed at mimicking the results of the Berlin Patient and others have been developed including ongoing human clinical trials.  There is an urgent need for strategies that expand gene therapy beyond CCR5 modification to target multiple stages of HIV…

339 – Sustained Inflammation and Delayed Resolution of COVID-19 Disease in SIV-Infected Macaques

Background COVID-19 continues to be a health challenge with critical knowledge gaps existing in the understanding of mechanisms driving severity in comorbid conditions. Clinical observations points to a higher susceptibility to COVID-19 in people living with HIV (PLHIV) but the precise mechanisms are still unknown. Methods Our group was amongst few that established the rhesus…